Dr. David Palchak, MD
Claim this profilePCR Oncology
Studies Bladder Cancer
Studies Head and Neck Cancers
2 reported clinical trials
2 drugs studied
Affiliated Hospitals
PCR Oncology
More about David Palchak, MD
Clinical Trial Related1 year of experience running clinical trials · Led 2 trials as a Principal Investigator · 0 Active Clinical TrialsTreatments David Palchak, MD has experience with
- Ulixertinib (BVD-523)
- Nab-sirolimus
Breakdown of trials David Palchak, MD has run
Bladder Cancer
Head and Neck Cancers
Stomach Cancer
Esophageal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David Palchak, MD specialize in?
David Palchak, MD focuses on Bladder Cancer and Head and Neck Cancers. In particular, much of their work with Bladder Cancer has involved treating patients, or patients who are undergoing treatment.
Is David Palchak, MD currently recruiting for clinical trials?
No, David Palchak, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that David Palchak, MD has studied deeply?
Yes, David Palchak, MD has studied treatments such as Ulixertinib (BVD-523), nab-sirolimus.
What is the best way to schedule an appointment with David Palchak, MD?
Apply for one of the trials that David Palchak, MD is conducting.
What is the office address of David Palchak, MD?
The office of David Palchak, MD is located at: PCR Oncology, Arroyo Grande, California 93420 United States. This is the address for their practice at the PCR Oncology.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.